Institutional
Vitruvian Partners LLP
CIK 0001692590
$111.8M
Reported AUM
7
Positions
Q1 2026
Period
2026-05-11
Filed
The Brief · Vitruvian Partners LLP · Q1 2026
AI · grounded in 13F
Vitruvian Partners LLP reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HNGE | HINGE HEALTH INC | $75.11 | 1.42% | 67.10% | 45.14% | $48.2M | 43.09% | — | HELD |
| 2 | MQ | MARQETA | $17.65 | -3.87% | -17.00% | -84.19% | $28.0M | 25.00% | — | HELD |
| 3 | CARG | CARGURUS INC | $36.00 | -2.89% | 16.35% | 22.02% | $16.1M | 14.40% | — | HELD |
| 4 | XMTR | XOMETRY INC | $84.91 | 4.87% | 160.61% | 11.42% | $7.8M | 7.01% | — | HELD |
| 5 | GLBE | GLOBAL-E | $39.87 | -0.97% | 26.89% | -49.51% | $6.5M | 5.80% | — | HELD |
| 6 | MXCT | MAXCYTE | $1.05 | 3.96% | -50.49% | -93.42% | $3.5M | 3.17% | — | HELD |
| 7 | RXST | RXSIGHT | $6.08 | -0.82% | -21.41% | -60.14% | $1.7M | 1.54% | — | HELD |
Source: SEC EDGAR · accession 0001420506-26-000881. 13F discloses long positions only — shorts, foreign equities, and options are excluded.